Ascendis markets second commercial product – launching in Germany and Austria
Biotech company Ascendis Pharma is now putting its drug, Yorvipath, on the market in Germany and Austria, the Danish-American company informs in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.